Literature DB >> 10357230

Biochemical dysfunction and memory loss: the case of Alzheimer's dementia.

E von Linstow Roloff1, B Platt.   

Abstract

Among the different types of cognitive impairment that appear with increasing age, Alzheimer's disease (AD) is rated as the most frequent. Despite intensive research, key questions concerning AD aetiology remain elusive, but it appears that many biochemical events crucial for neuronal communication and synaptic plasticity fail during the course of the disease. The aim of this review is therefore to provide an overview of intracellular cascades involved in AD pathology. For almost all factors. it is a matter of controversy whether their contribution should be considered to be cause or effect. However, intracellular signalling may be crucial as it is in learning and memory mechanisms and malfunction of biochemical pathways may be a common denominator in neurodegenerative processes, thus providing new venues for treatment and therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357230     DOI: 10.1007/s000180050318

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  9 in total

1.  Anterior thalamic lesions produce chronic and profuse transcriptional de-regulation in retrosplenial cortex: A model of retrosplenial hypoactivity and covert pathology.

Authors:  G L Poirier; K L Shires; D Sugden; E Amin; K L Thomas; D A Carter; J P Aggleton
Journal:  Thalamus Relat Syst       Date:  2008-03

2.  Galanthamine plus estradiol treatment enhances cognitive performance in aged ovariectomized rats.

Authors:  R B Gibbs; A M Chipman; R Hammond; D Nelson
Journal:  Horm Behav       Date:  2011-08-26       Impact factor: 3.587

3.  Loss of muscarinic M1 receptor exacerbates Alzheimer's disease-like pathology and cognitive decline.

Authors:  Rodrigo Medeiros; Masashi Kitazawa; Antonella Caccamo; David Baglietto-Vargas; Tatiana Estrada-Hernandez; David H Cribbs; Avraham Fisher; Frank M LaFerla
Journal:  Am J Pathol       Date:  2011-06-23       Impact factor: 4.307

Review 4.  Biologic and plastic effects of experimental traumatic brain injury treatment paradigms and their relevance to clinical rehabilitation.

Authors:  Alexandra N Garcia; Mansi A Shah; C Edward Dixon; Amy K Wagner; Anthony E Kline
Journal:  PM R       Date:  2011-06       Impact factor: 2.298

Review 5.  GPR30 is positioned to mediate estrogen effects on basal forebrain cholinergic neurons and cognitive performance.

Authors:  R Hammond; R B Gibbs
Journal:  Brain Res       Date:  2010-12-05       Impact factor: 3.252

6.  Donepezil plus estradiol treatment enhances learning and delay-dependent memory performance by young ovariectomized rats with partial loss of septal cholinergic neurons.

Authors:  R B Gibbs; A M Chipman; D Nelson
Journal:  Horm Behav       Date:  2011-02-03       Impact factor: 3.587

7.  GPR30 co-localizes with cholinergic neurons in the basal forebrain and enhances potassium-stimulated acetylcholine release in the hippocampus.

Authors:  R Hammond; D Nelson; R B Gibbs
Journal:  Psychoneuroendocrinology       Date:  2010-08-08       Impact factor: 4.905

Review 8.  Estrogen therapy and cognition: a review of the cholinergic hypothesis.

Authors:  Robert B Gibbs
Journal:  Endocr Rev       Date:  2009-12-17       Impact factor: 19.871

9.  Evaluation of a combined therapeutic regimen of 8-OH-DPAT and environmental enrichment after experimental traumatic brain injury.

Authors:  Anthony E Kline; Rose L McAloon; Kate A Henderson; Utsav K Bansal; Bhaskar M Ganti; Rashid H Ahmed; Robert B Gibbs; Christopher N Sozda
Journal:  J Neurotrauma       Date:  2010-10-28       Impact factor: 5.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.